Posts

Showing posts with the label Contrast Media Injectors Market

Global Contrast Media Injectors Market: Trends, Growth, and Forecast to 2030

  The global  contrast media injectors market  is expected to reach USD 2.08 billion by 2030, registering a CAGR of 7.50% during the forecast period, according to a new report by Grand View Research, Inc. The market is expected to grow because of the rising demand for minimally invasive surgical procedures, along with the increasing usage of consumables for several diagnostic procedures, which are supporting the market growth of contrast media injectors.   COVID-19 had a significant impact on the contrast media injector market, in 2019, with around a 30-40% reduction in sales due to the imposed lockdown and rapid decline in imaging case volume. However, the market is expected to return to peak levels of 2019 by 2022. This is due to the launch of COVID-19 vaccines and ease in restrictions, import & export of raw materials have resumed; therefore, the market is expected to grow at a significant rate over the forecast period. Technological advancements such as IT-en...

Contrast Media Injectors Market expected to expand at a CAGR of 4.83% from 2022 to 2030.

  Contrast Media Injectors Industry Overview The global  contrast media injectors market  is expected to reach USD 1.65 billion by 2030, registering a CAGR of 4.83% during the forecast period, according to a new report by Grand View Research, Inc. The market is expected to grow because of the rising demand for minimally invasive surgical procedures, along with the increasing usage of consumables for several diagnostic procedures, which are supporting the market growth of contrast media injectors.   Contrast Media Injectors Market Segmentation Grand View Research has segmented the global contrast media injectors market based on the product, type, application, end use, and regions: Based on the Product Insights, the market is segmented into Injector Systems, and Consumables The injector systems led the market and accounted for more than 61.33% share of the global revenue in 2021. Contrast agents are delivered into the bloodstream of patients during CT, MRI, and ...